Human TNF-α has been intensively studied, and drugs (e.g., TNF-α blockers) were developed in the form of TNFα antibodies to treat many diseases, including osteoporosis, psoriasis, arthritis and Crohn disease. Here, TNF is linked to osteoporosis.